These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7894537)

  • 21. Serotonergic mechanisms of the median raphe nucleus-dorsal hippocampus in conditioned fear: Output circuit involves the prefrontal cortex and amygdala.
    Almada RC; Borelli KG; Albrechet-Souza L; Brandão ML
    Behav Brain Res; 2009 Nov; 203(2):279-87. PubMed ID: 19464321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotonergic innervation of the hippocampus and nucleus accumbens septi and the anxiolytic-like action of midazolam and 5-HT1A receptor agonists.
    Stefański R; Pałejko W; Bidziński A; Kostowski W; Płaźnik A
    Neuropharmacology; 1993 Oct; 32(10):977-85. PubMed ID: 7905194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of serotonergic affect control.
    Kennett GA
    Adv Exp Med Biol; 1991; 294():231-43. PubMed ID: 1685293
    [No Abstract]   [Full Text] [Related]  

  • 24. Serotonergic mechanisms in anxiolytic effect of tandospirone in the Vogel conflict test.
    Shimizu H; Tatsuno T; Tanaka H; Hirose A; Araki Y; Nakamura M
    Jpn J Pharmacol; 1992 May; 59(1):105-12. PubMed ID: 1354771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotonin receptor subtypes: implications for psychopharmacology.
    Cowen PJ
    Br J Psychiatry Suppl; 1991 Sep; (12):7-14. PubMed ID: 1840764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A pharmacological analysis of the anxiolytic action of derivations of benzodiazepine, GABA and beta-carboline in various tests of tension reaction].
    Talalaenko AN
    Farmakol Toksikol; 1989; 52(6):26-9. PubMed ID: 2576232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-HT(3) receptor antagonists and anxiety; a preclinical and clinical review.
    Olivier B; van Wijngaarden I; Soudijn W
    Eur Neuropsychopharmacol; 2000 Mar; 10(2):77-95. PubMed ID: 10706989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antidepressant treatment and limbic serotonergic mechanisms regulating rat locomotor activity.
    Plaznik A; Stefanski R; Palejko W; Bidzinski A; Kostowski W; Jessa M; Nazar M
    Pharmacol Biochem Behav; 1994 Jun; 48(2):315-25. PubMed ID: 8090797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Some behavioral effects of microinjections of serotonin and noradrenaline into the limbic structures of the rat brain.
    Płaźnik A
    Pol J Pharmacol Pharm; 1984; 36(5):541-54. PubMed ID: 6533630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serotonergic mechanisms in the nucleus accumbens affected by chronic desipramine treatment.
    Płaźnik A; Stefański R; Pałejko W; Kostowski W
    Pharmacol Biochem Behav; 1991 May; 39(1):43-8. PubMed ID: 1833782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The agonists of I-A serotoninergic receptors restore in rats behavior impaired by L-dihydroxyphenylalanine].
    Bondarenko NA; Bondarenko NA; Baran L; Klodzinska A
    Biull Eksp Biol Med; 1990 Dec; 110(12):627-8. PubMed ID: 2083366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonin and psychiatric disorders. A key to new therapeutic approaches.
    Costall B; Naylor RJ
    Arzneimittelforschung; 1992 Feb; 42(2A):246-9. PubMed ID: 1586395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Central serotonergic mechanisms on head twitch response induced by benzodiazepine receptor agonists.
    Tadano T; Hozumi M; Satoh N; Oka R; Hishinuma T; Mizugaki M; Arai Y; Yasuhara H; Kinemuchi H; Niijima F; Nakagawasai O; Tan-no K; Kisara K
    Pharmacology; 2001; 62(3):157-62. PubMed ID: 11287817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pharmacology of new anxiolytics acting on 5-HT neurones.
    Marsden CA
    Postgrad Med J; 1990; 66 Suppl 2():S2-6. PubMed ID: 1975437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Benzodiazepines and limbic system. Anxiety and vigilance (author's transl)].
    Gekiere F; Allegre G; Brindeau F; Borenstein P
    Pathol Biol (Paris); 1980 Jan; 28(1):63-7. PubMed ID: 6102366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of serotonin1A and serotonin2 receptors in the central regulation of the cardiovascular system.
    McCall RB; Clement ME
    Pharmacol Rev; 1994 Sep; 46(3):231-43. PubMed ID: 7831380
    [No Abstract]   [Full Text] [Related]  

  • 37. Anxiolytic potential of 5-HT3 receptor antagonists.
    Costall B; Naylor RJ
    Pharmacol Toxicol; 1992 Mar; 70(3):157-62. PubMed ID: 1349746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implication of 5-HT2 receptor subtypes in the mechanism of action of the GABAergic compound etifoxine in the four-plate test in Swiss mice.
    Bourin M; Hascoët M
    Behav Brain Res; 2010 Apr; 208(2):352-8. PubMed ID: 20006646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Recent progress in development of psychotropic drugs (1)--Anti-anxiety drugs].
    Kudo Y; Kudo T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Apr; 15(2):75-86. PubMed ID: 7796324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A new group of anxiolytic drugs with a mechanism of action different from that of benzodiazepine derivatives].
    Kostowski W; Płaźnik A
    Pol Tyg Lek; 1988 Dec 19-26; 43(51-52):1647-9, 1683. PubMed ID: 2908340
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.